tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Stock Forecast & Price Target

230 Followers
See the Price Targets and Ratings of:

VVOS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Vivos
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VVOS Stock 12 Month Forecast

There Are No Analyst Ratings for VVOS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VVOS Financial Forecast

VVOS Earnings Forecast

The previous quarter’s earnings for VVOS were -$0.46.
The previous quarter’s earnings for VVOS were -$0.46.

VVOS Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on VVOS
Unknown Analyst
Alliance Global Partners
Not Ranked
Alliance Global Partners
$4$2.5
Hold
12.61%
Upside
Reiterated
01/09/26
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS)
Ascendiant Analyst forecast on VVOS
Ascendiant
Ascendiant
$6.5$5.5
Buy
147.75%
Upside
Reiterated
12/01/25
We are using the 10Q share count of 8.99 million shares, as of November 2025.
H.C. Wainwright Analyst forecast on VVOS
H.C. Wainwright
H.C. Wainwright
$7
Buy
215.32%
Upside
Initiated
11/17/25
Vivos Therapeutics initiated with a Buy at H.C. WainwrightVivos Therapeutics initiated with a Buy at H.C. Wainwright
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on VVOS
Unknown Analyst
Alliance Global Partners
Not Ranked
Alliance Global Partners
$4$2.5
Hold
12.61%
Upside
Reiterated
01/09/26
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS)
Ascendiant Analyst forecast on VVOS
Ascendiant
Ascendiant
$6.5$5.5
Buy
147.75%
Upside
Reiterated
12/01/25
We are using the 10Q share count of 8.99 million shares, as of November 2025.
H.C. Wainwright Analyst forecast on VVOS
H.C. Wainwright
H.C. Wainwright
$7
Buy
215.32%
Upside
Initiated
11/17/25
Vivos Therapeutics initiated with a Buy at H.C. WainwrightVivos Therapeutics initiated with a Buy at H.C. Wainwright
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Vivos Therapeutics

3 Months
xxx
Success Rate
5/10 ratings generated profit
50%
Average Return
+16.25%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +16.25% per trade.
1 Year
Lucas WardAscendiant
Not Ranked
Success Rate
1/10 ratings generated profit
10%
Average Return
-33.95%
reiterated a buy rating 4 months ago
Copying Lucas Ward's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -33.95% per trade.
2 Years
xxx
Success Rate
0/10 ratings generated profit
0%
Average Return
-56.24%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -56.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VVOS Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
1
2
2
2
1
Buy
0
0
0
0
0
Hold
32
30
18
25
25
Sell
8
7
4
6
6
Strong Sell
0
0
0
0
0
total
41
39
24
33
32
In the current month, VVOS has received 1 Buy Ratings, 25 Hold Ratings, and 6 Sell Ratings. VVOS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

VVOS Stock Forecast FAQ

What is VVOS’s average 12-month price target, according to analysts?
Currently, no data Available
What is VVOS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VVOS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VVOS a Buy, Sell or Hold?
      Currently, no data Available
      What is Vivos Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Vivos Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of VVOS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.